Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-18 Purchase | 2022-11-21 5:54 pm | POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director | 6,000 | $6.33 | $37,980 | 41,872 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-27 Disposition | 2023-12-27 5:41 pm | N/A 2026-12-01 | POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director | 131,235 | $0 | 0 (Direct) | View |
| 2023-12-26 Equity Swap | 2023-12-27 5:41 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director | 41,872 | $0 | 0 (Indirect) | View |
| 2023-06-01 Option Award | 2023-06-05 5:36 pm | N/A 2029-06-01 | POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director | 44,749 | $0 | 44,749 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 4:05 pm | N/A 2028-06-02 | POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director | 25,614 | $0 | 25,614 (Direct) | View |
| 2021-06-30 Option Award(A) | 2022-02-08 2:25 pm | N/A N/A | POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director | 35,872 | $0 | 35,872 (Indirect) | View |
| 2021-07-06 Option Award | 2021-07-08 4:33 pm | N/A 2027-07-06 | POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2021-06-30 Option Award | 2021-06-30 9:28 pm | N/A 2026-12-01 | POINT Biopharma Global Inc. | PNT | GOODMAN JONATHAN R. Director | 57,395 | $0 | 93,267 (Direct) | View |